CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
Atrial fibrillation is the most common form of heart rhythm disorder and is linked to serious complications, including stroke and heart failure. While earlier research pointed to a possible ...
8hon MSN
Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study
Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early ...
February 24, 2026—iVascular announced the enrollment of the first patient in the FENCO clinical study evaluating the company’s iCover ball ...
Phase 2/3 study of livmoniplimab in combination with budigalimab in patients with locally advanced or metastatic hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
India: A recent multicenter study published in the Indian Journal of Medical Research in September 2025 reports that the ...
A large, multi-center study published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new ...
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results